Matrix metalloproteinase-9 is increased and correlates with severity in Guillain-Barre syndrome

Abstract

Circulating matrix metalloproteinases (MMP-9) correlates with disease severity in Guillain-Barré syndrome (GBS). MMP-9 likely represents an important molecule in the pathogenesis of GBS and therefore could represent an interesting therapeutic target.